SEC Comment Letter 0000000000-22-013978 to Marker Therapeutics, Inc. (MRKR) (CIK 0001094038) (MRKR)
Marker Therapeutics, Inc. (MRKR) (CIK 0001094038)
Date: Dec. 29, 2022 · CIK: 0001094038 · Accession: 0000000000-22-013978
AI Filing Summary & Sentiment
File numbers found in text: 333-268979
Letter
United States securities and exchange commission logo December 29, 2022 Peter Hoang Chief Executive Officer Marker Therapeutics, Inc. 4551 Kennedy Commerce Dr. Houston, Texas 77027 Re:Marker Therapeutics, Inc. Registration Statement on Form S-1 Filed December 23, 2022 File No. 333-268979 Dear Peter Hoang: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
December 29, 2022
Peter Hoang
Chief Executive Officer
Marker Therapeutics, Inc.
4551 Kennedy Commerce Dr.
Houston, Texas 77027
Re:Marker Therapeutics, Inc.
Registration Statement on Form S-1
Filed December 23, 2022
File No. 333-268979
Dear Peter Hoang:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences